Carrie K. Jones

8.6k citations

161 papers · 5.8k indexed · h-index 43

Cellular and Molecular Neuroscience top 0.2%
Molecular Biology top 2%
Cognitive Neuroscience top 2%
Pharmacology top 2%
Physiology top 5%

Co-authors: P. Jeffrey Conn Craig W. Lindsley Colleen M. Niswender Harlan E. Shannon Michael Bubser Thomas M. Bridges Nellie Byun Zixiu Xiang
Topics: Neuroscience and Neuropharmacology Research (108 papers)Receptor Mechanisms and Signaling (100 papers)Nicotinic Acetylcholine Receptors Study (26 papers)
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Neuron
Partner nations: United States Australia Belgium

In The Last Decade

Carrie K. Jones

157 papers receiving 5.7k citations

Peers

Countries citing papers authored by Carrie K. Jones

Since Specialization

Citations

This map shows the geographic impact of Carrie K. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie K. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie K. Jones more than expected).

Fields of papers citing papers by Carrie K. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie K. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie K. Jones. The network helps show where Carrie K. Jones may publish in the future.

Co-authorship network of co-authors of Carrie K. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Carrie K. Jones. A scholar is included among the top collaborators of Carrie K. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carrie K. Jones. Carrie K. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shank3 modulates Rpl3 expression and protein synthesis via mGlu5: implications for Phelan McDermid syndrome 2025 ·Molecular Psychiatry ·(unknown),(unknown),Antonio G. Zippo,(unknown),(unknown),Cinzia Vicidomini,Luisa Ponzoni,Mariaelvina Sala,Carrie K. Jones,P. Jeffrey Conn,Tobias M. Boeckers,Carlo Sala,Chiara Verpelli	1
2	Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) 2024 ·ACS Chemical Neuroscience ·Julie L. Engers,(unknown),Sichen Chang,Vincent B. Luscombe,Alice L. Rodriguez,Colleen M. Niswender,Hyekyung P. Cho,Michael Bubser,(unknown),Carrie K. Jones,Weimin Peng,Jerri M. Rook,Thomas M. Bridges,Olivier Boutaud,P. Jeffrey Conn,Darren W. Engers,Craig W. Lindsley,Kayla J. Temple	1
3	The M₄ muscarinic acetylcholine receptor positive allosteric modulator VU0467154 normalizes non‐rapid eye movement sleep deficits in non‐pathologically aged mice. 2023 ·Alzheimer s & Dementia ·(unknown),(unknown),(unknown),Michael Bubser,Craig W. Lindsley,Carrie K. Jones	0
4	Biomechanical analysis of wheelchair athletes with paraplegia during cross-training exercises 2021 ·Journal of Spinal Cord Medicine ·Carrie K. Jones,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Kenneth Lee,Brooke A. Slavens	2
5	Partial mGlu5 Negative Allosteric Modulator M-5MPEP Demonstrates Antidepressant-Like Effects on Sleep Without Affecting Cognition or Quantitative EEG 2021 ·Frontiers in Neuroscience ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Craig W. Lindsley,Carrie K. Jones,Robert W. Gould	10
6	Sexual Dimorphism in Stress‐induced Hyperthermia in SNAP25Δ3 mice, a mouse model with disabled Gβγ regulation of the exocytotic fusion apparatus 2020 ·European Journal of Neuroscience ·(unknown),(unknown),(unknown),Carrie K. Jones,Zack Zurawski,Heidi E. Hamm	4
7	Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents 2020 ·Biological Psychiatry ·Leigh C. Walker,(unknown),Nicola A. Chen,Patricia Rueda,Victoria M. Perreau,(unknown),(unknown),Piyarat Govitrapong,Xiaojian Jia,Craig W. Lindsley,Carrie K. Jones,Darren Riddy,Arthur Christopoulos,Christopher J. Langmead,Andrew J. Lawrence	30
8	In Vitro to in Vivo Translation of Allosteric Modulator Concentration-Effect Relationships: Implications for Drug Discovery 2019 ·ACS Pharmacology & Translational Science ·Karen J. Gregory,Thomas M. Bridges,Rocco G. Gogliotti,Shaun R. Stauffer,Meredith J. Noetzel,Carrie K. Jones,Craig W. Lindsley,P. Jeffrey Conn,Colleen M. Niswender	6
9	Disabling the Gβγ-SNARE interaction disrupts GPCR-mediated presynaptic inhibition, leading to physiological and behavioral phenotypes 2019 ·Science Signaling ·Zack Zurawski,(unknown),Lillian J. Brady,Brian Page,Emily Church,(unknown),Michael R. Dohn,(unknown),Karren Hyde,Douglas P. Mortlock,Carrie K. Jones,Danny G. Winder,Simon Alford,Heidi E. Hamm	26
10	Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders 2019 ·Advances in pharmacology ·(unknown),Robert W. Gould,Andrew S. Felts,Carrie K. Jones	15
11	Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators 2018 ·Molecular Psychiatry ·Samantha E. Yohn,Daniel J. Foster,Dan P. Covey,Mark S. Moehle,(unknown),Pedro M. García-Barrantes,Hyekyung P. Cho,Michael Bubser,Anna L. Blobaum,Max E. Joffe,Joseph F. Cheer,Carrie K. Jones,Craig W. Lindsley,P. Jeffrey Conn	39
12	Muscarinic M5 receptors modulate ethanol seeking in rats 2018 ·Neuropsychopharmacology ·(unknown),Christina J. Perry,David M. Shackleford,Craig W. Lindsley,Carrie K. Jones,Nicola A. Chen,Patrick M. Sexton,Arthur Christopoulos,Christopher J. Langmead,Andrew J. Lawrence	31
13	A Novel M ₁ PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity 2018 ·ACS Chemical Neuroscience ·Jerri M. Rook,(unknown),Hyekyung P. Cho,Pedro M. García-Barrantes,Sean P. Moran,James Maksymetz,Kellie D. Nance,Jonathan W. Dickerson,(unknown),Sichen Chang,Joel M. Harp,Anna L. Blobaum,Colleen M. Niswender,Carrie K. Jones,Shaun R. Stauffer,P. Jeffrey Conn,Craig W. Lindsley	45
14	mGlu ₇ potentiation rescues cognitive, social, and respiratory phenotypes in a mouse model of Rett syndrome 2017 ·Science Translational Medicine ·Rocco G. Gogliotti,(unknown),Nicole M. Fisher,J. Paige Adams,Rocio Zamorano,Adam G. Walker,Anna L. Blobaum,Darren W. Engers,Corey R. Hopkins,J. Scott Daniels,Carrie K. Jones,Craig W. Lindsley,Zixiu Xiang,P. Jeffrey Conn,Colleen M. Niswender	63
15	Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia 2011 ·Neuropsychopharmacology ·Carrie K. Jones,Nellie Byun,Michael Bubser	162
16	The antipsychotic potential of muscarinic allosteric modulation 2010 ·Drug News & Perspectives ·Thomas M. Bridges,Evan P. Lebois,Corey R. Hopkins,Michael R. Wood,Carrie K. Jones,P. Jeffrey Conn,Craig W. Lindsley	50
17	Discovery of the First Highly M5-Preferring Muscarinic Acetylcholine Receptor Ligand, an M5 Positive Allosteric Modulator Derived from a Series of 5-Trifluoromethoxy N -Benzyl Isatins 2009 ·Journal of Medicinal Chemistry ·Thomas M. Bridges,Joy E. Marlo,Colleen M. Niswender,Carrie K. Jones,Satyawan Jadhav,Patrick R. Gentry,(unknown),C. David Weaver,P. Jeffrey Conn,Craig W. Lindsley	88
18	Novel allosteric modulators of metabotropic glutamate receptors subtypes 2 and 5 for the treatment of schizophrenia 2008 ·Neuropharmacology ·Carrie K. Jones,Fangfang Xiang,Andrew K. Jones,Nellie Byun,(unknown),(unknown),Jennifer Ayala,Colleen M. Niswender,Satyawan Jadhav,Douglas J. Sheffler,Alexis S. Hammond,(unknown),A.K. Thompson,Richard D. Williams,(unknown),C. David Weaver,Craig W. Lindsley,P. Jeffrey Conn	1
19	Permissive antagonism induced by novel allosteric antagonists of metabotropic glutamate receptor 7 2006 ·Neuropsychopharmacology ·Colleen M. Niswender,(unknown),Richard D. Williams,Jennifer Ayala,Qingwei Luo,(unknown),Carrie K. Jones,Darren Orton,C. David Weaver,P. Jeffrey Conn	2
20	Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing 2005 ·Neuropharmacology ·Carrie K. Jones,Elizabeth L. Eberle,Stephen C. Peters,James A. Monn,Harlan E. Shannon	70

About Carrie K. Jones

Carrie K. Jones is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Biological Psychiatry, having authored 161 papers that have together received 5.8k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (108 papers), Receptor Mechanisms and Signaling (100 papers) and Nicotinic Acetylcholine Receptors Study (26 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (4.0k citations), Biological Psychiatry (245 citations) and Molecular Biology (3.9k citations). Carrie K. Jones has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Harlan E. Shannon, Michael Bubser, Thomas M. Bridges, Nellie Byun, Zixiu Xiang, J. Scott Daniels and Alice L. Rodriguez. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neuron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact